US 12097183
Pharmaceutical composition for treating migraine
granted A61KA61K31/4045A61K9/0019
Quick answer
US patent 12097183 (Pharmaceutical composition for treating migraine) held by Tonix Medicines, Inc. expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tonix Medicines, Inc.
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4045, A61K9/0019, A61K9/08, A61P